We are excited to announce that the Thoracic Surgical Lung Cancer Program has expanded to HonorHealth John C. Lincoln Medical Center.

Lung cancer is the leading cause of all cancer deaths. However, when diagnosed at the earliest stage, known as stage IA-1, the average 5-year survival rate is 92%.1 While early-stage diagnosis can be difficult, at HonorHealth, we offer life-enhancing technology and better cancer care solutions so that our patients have access to quality care.

Using the latest robotic-assisted platform, our lung care physicians at HonorHealth John C. Lincoln Medical Center are able to perform minimally invasive biopsy procedures for lung biopsies on even the smallest nodules. The ultra-thin catheter and integrated vision probe provides the physician direct vision to reach all parts of the lungs for a more precise biopsy.

“This investment enables us to provide our patients with comprehensive quality care – from biopsy to surgery. It allows us to navigate far into the peripheral lung with more stability and precision, compared to manual techniques,” said Richard Gillespie, MD, medical director, thoracic surgical oncology at HonorHealth, “We are thrilled to now offer this procedure at HonorHealth John C. Lincoln Medical Center.”